Skip to content

Alg12 Congenital Disorder Of Glycosylation C2931001

Published: July 22, 2026Updated: August 25, 2026

A rare genetic disorder affecting protein glycosylation, caused by mutations in the ALG12 gene. It often leads to immune deficiency, developmental delay, and distinctive facial features. Treatment focuses on supportive care and managing infections.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Global developmental delay

(neurological)

Severe feeding difficulties

(gastrointestinal)

Coagulopathy

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive multidisciplinary monitoring

Regular monitoring by a team including neurologists, cardiologists, and metabolic specialists to track disease progression and manage complications proactively.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Nutritional support therapy

Customized nutritional plans addressing feeding difficulties and ensuring adequate caloric and nutrient intake for optimal growth and metabolic function.

dietary

Additional treatment options

Early intervention physical therapy

Structured physical therapy programs designed to maintain joint mobility, prevent contractures, and support motor development.

physical_therapy

Symptomatic seizure management

Anticonvulsant therapy for seizure control when appropriate, with regular neurological assessment to optimize medication regimens.

medication

Neurodevelopmental support services

Cognitive and behavioral support including developmental therapy, educational support, and family counseling to address intellectual disability and behavioral challenges.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alg12 Congenital Disorder Of Glycosylation C2931001?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Jaeken J, Matthijs G, Cassiman JJ. Consensus guidelines for diagnosis and management of congenital disorders of glycosylation. J Inherit Metab Dis. 2022.

guideline2022
2

Freeze HH, Eklund EA, Ng BG. Neurological aspects of human glycosylation disorders. Nat Rev Neurol. 2021.

review2021
3

Schwartz ML, Cox TM, Linton KJ. Clinical phenotype and molecular characterization of Alg12-CDG: a systematic review. Mol Genet Metab. 2020.

clinical_trial2020
4

Chang IJ, He M, Wang C. Update on the glycosylation pathway of human disease: focus on ALG gene mutations. Orphanet J Rare Dis. 2023.

review2023

Medication Comparisons

Compare medications used to treat Alg12 Congenital Disorder Of Glycosylation C2931001. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy